BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ozurdex dexamethasone intravitreal implant regulatory update

EMA's CHMP issued a positive opinion to extend the indication for Ozurdex dexamethasone intravitreal implant from Allergan to include the treatment of adult patients...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >